Book contents
- Placental–Fetal Growth Restriction
- Placental–Fetal Growth Restriction
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Glossary and Commonly Used Abbreviations
- Section 1 Basic Principles
- Section 2 Maternal Cardiovascular Characteristics and the Placenta
- Section 3 Screening for Placental–Fetal Growth Restriction
- Section 4 Prophylaxis and Treatment
- Section 5 Characteristics of Fetal Growth Restriction
- Section 6 Management of Fetal Growth Restriction
- Chapter 22 Management of Early-Onset Fetal Growth Restriction (Less than 34 Weeks)
- Chapter 23 Late-Onset Fetal Growth Restriction
- Chapter 24 Severe Fetal Growth Restriction: Pregnancy Management at the Limits of Viability
- Chapter 25 Fetal Growth Restriction in Twin Pregnancies
- Section 7 Postnatal Aspects of Fetal Growth Restriction
- Index
- References
Chapter 24 - Severe Fetal Growth Restriction: Pregnancy Management at the Limits of Viability
from Section 6 - Management of Fetal Growth Restriction
Published online by Cambridge University Press: 23 July 2018
Book contents
- Placental–Fetal Growth Restriction
- Placental–Fetal Growth Restriction
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Glossary and Commonly Used Abbreviations
- Section 1 Basic Principles
- Section 2 Maternal Cardiovascular Characteristics and the Placenta
- Section 3 Screening for Placental–Fetal Growth Restriction
- Section 4 Prophylaxis and Treatment
- Section 5 Characteristics of Fetal Growth Restriction
- Section 6 Management of Fetal Growth Restriction
- Chapter 22 Management of Early-Onset Fetal Growth Restriction (Less than 34 Weeks)
- Chapter 23 Late-Onset Fetal Growth Restriction
- Chapter 24 Severe Fetal Growth Restriction: Pregnancy Management at the Limits of Viability
- Chapter 25 Fetal Growth Restriction in Twin Pregnancies
- Section 7 Postnatal Aspects of Fetal Growth Restriction
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Placental-Fetal Growth Restriction , pp. 219 - 223Publisher: Cambridge University PressPrint publication year: 2018
References
Papageorghiou, AT, Leslie, K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol 2007;19(2):103–9.CrossRefGoogle ScholarPubMed
Papageorghiou, AT, Yu, CK, Nicolaides, KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004;18(3):383–96.CrossRefGoogle ScholarPubMed
Ananth, CV, Vintzileos, AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol 2006;195(6):1557–63.CrossRefGoogle ScholarPubMed
Lee, MJ, Conner, EL, Charafeddine, L, Woods, JR, Jr., Del Priore, G. A critical birth weight and other determinants of survival for infants with severe intrauterine growth restriction. Ann N Y Acad Sci 2001;943:326–39.Google Scholar
Petersen, SG, Wong, SF, Urs, P, Gray, PH, Gardener, GJ. Early onset, severe fetal growth restriction with absent or reversed end-diastolic flow velocity waveform in the umbilical artery: Perinatal and long-term outcomes. Aust N Z J Obstet Gynaecol 2009;49(1):45–51.CrossRefGoogle ScholarPubMed
Batton, DG, DeWitte, DB, Espinosa, R, Swails, TL. The impact of fetal compromise on outcome at the border of viability. Am J Obstet Gynecol 1998;178(5):909–15.Google Scholar
Lees, CC, Marlow, N, Van Wassenaer-Leemhuis, A, Arabin, B, Bilardo, CM, Brezinka, C, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): A randomised trial. Lancet 2015;385(9983):2162–72.Google Scholar
Baschat, AA, Cosmi, E, Bilardo, CM, Wolf, H, Berg, C, Rigano, S, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007;109(2 Pt 1):253–61.Google Scholar
Strauss, RS. Adult functional outcome of those born small for gestational age: Twenty-six-year follow-up of the 1970 British Birth Cohort. JAMA 2000;283(5):625–32.CrossRefGoogle ScholarPubMed
Hediger, ML, Overpeck, MD, Maurer, KR, Kuczmarski, RJ, McGlynn, A, Davis, WW. Growth of infants and young children born small or large for gestational age: Findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 1998;152(12):1225–31.Google Scholar
Lundgren, EM, Cnattingius, S, Jonsson, B, Tuvemo, T. Intellectual and psychological performance in males born small for gestational age with and without catch-up growth. Pediatr Res 2001;50(1):91–6.CrossRefGoogle ScholarPubMed
Sung, IK, Vohr, B, Oh, W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: Comparison with control subjects matched by birth weight and gestational age. J Pediatr 1993;123(4):618–24.Google Scholar
Stein, CE, Fall, CH, Kumaran, K, Osmond, C, Cox, V, Barker, DJ. Fetal growth and coronary heart disease in south India. Lancet 1996;348(9037):1269–73.Google Scholar
Bernstein, IM, Horbar, JD, Badger, GJ, Ohlsson, A, Golan, A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182(1 Pt 1):198–206.CrossRefGoogle ScholarPubMed
Van Wassenaer, AG, Westera, J, Van Schie, PE, Houtzager, BA, Cranendonk, A, De Groot, L, et al. Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancy. Am J Obstet Gynecol 2011;204(6):510 e1–9.Google Scholar
Lees, C, Marlow, N, Arabin, B, Bilardo, CM, Brezinka, C, Derks, JB, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: Cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 2013;42(4):400–8.Google Scholar
Rep, A, Ganzevoort, W, Van Wassenaer, AG, Bonsel, GJ, Wolf, H, De Vries, JI. One-year infant outcome in women with early-onset hypertensive disorders of pregnancy. BJOG 2008;115(2):290–8.Google Scholar
Lawin-O’Brien, AR, Dall’Asta, A, Knight, C, Sankaran, S, Scala, C, Khalil, A, et al. Short-term outcome of periviable small-for-gestational-age babies: Is our counseling up to date? Ultrasound Obstet Gynecol 2016;48(5):636–41.Google Scholar
Zeitlin, J, El Ayoubi, M, Jarreau, PH, Draper, ES, Blondel, B, Kunzel, W, et al. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 2010;157(5):733–9 e1.Google Scholar
Morsing, E, Asard, M, Ley, D, Stjernqvist, K, Marsal, K. Cognitive function after intrauterine growth restriction and very preterm birth. Pediatrics 2011;127(4):e874–82.Google Scholar
Ganzevoort, W, Rep, A, Bonsel, GJ, De Vries, JI, Wolf, H, for the Pi. Dynamics and incidence patterns of maternal complications in early onset hypertension of pregnancy. BJOG 2007;114(6):741–50.Google Scholar
Visser, GHA, Bilardo, CM, Lees, C. Fetal growth restriction at the limits of viability. Fetal Diag Ther 2014; 36: 162–5.Google Scholar
Van Oostwaard, MF, Langenveld, J, Schuit, E, Papatsonis, DN, Brown, MA, Byaruhanga, RN, et al. Recurrence of hypertensive disorders of pregnancy: An individual patient data metaanalysis. Am J Obstet Gynecol 2015;212(5):624 e1–17.Google Scholar
Von Dadelszen, P, Dwinnell, S, Magee, LA, Carleton, BC, Gruslin, A, Lee, B, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 2011;118(5):624–8.CrossRefGoogle ScholarPubMed
Ganzevoort, W, Alfirevic, Z, Von Dadelszen, P, Kenny, L, Papageorghiou, A, Van Wassenaer-Leemhuis, A, et al. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction –a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis. Syst Rev 2014;3:23.CrossRefGoogle ScholarPubMed
Rumbold, A, Duley, L, Crowther, CA, Haslam, RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2008(1):CD004227.Google ScholarPubMed
Alers, NO, Jenkin, G, Miller, SL, Wallace, EM. Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction – a phase I pilot clinical trial: Study protocol. BMJ Open 2013;3(12):e004141.Google Scholar
Cottrell, EC, Sibley, CP. From pre-clinical studies to clinical trials: Generation of novel therapies for pregnancy complications. Int J Mol Sci 2015;16(6):12907–24.Google Scholar
Man, J, Hutchinson, JC, Heazell, AE, Ashworth, M, Jeffrey, I, Sebire, NJ. Stillbirth and intrauterine fetal death: Role of routine histopathological placental findings to determine cause of death. Ultrasound Obstet Gynecol 2016.Google Scholar
Kupferminc, MJ, Many, A, Bar-Am, A, Lessing, JB, Ascher-Landsberg, J. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. BJOG 2002;109(12):1373–6.Google Scholar
Brenner, B, Kupferminc, MJ. Inherited thrombophilia and poor pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2003;17(3):427–39.Google Scholar
Ganzevoort, W, Rep, A, De Vries, JI, Bonsel, GJ, Wolf, H, Investigators, P. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy. Hypertens Pregnancy 2007;26(4):433–45.Google Scholar